A new treatment for HIV has been approved. It is a single pill taken once daily. This pill combines two key components, one of which is used in existing treatments.

The treatment is intended for individuals with controlled HIV who face complex regimens. The pill is the result of work by Gilead Sciences. It offers a new option for those living with HIV, providing a simpler treatment.

Further details about this development are available from the original report.